← FDA DRUG APPROVALS

FDA ANDA · ANDA072668

TIMOLOL MALEATE

Sponsor: MYLAN

APPLICATION
ANDA072668
TYPE
ANDA
ORIGINAL APPROVAL
1990-06-08
LATEST ACTION
2003-08-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued, Prescription

Products

TIMOLOL MALEATEDiscontinued
TIMOLOL MALEATE 5MG · TABLET · ORAL
TIMOLOL MALEATEPrescription
TIMOLOL MALEATE 10MG · TABLET · ORAL
TIMOLOL MALEATEDiscontinued
TIMOLOL MALEATE 20MG · TABLET · ORAL

Approval history

2003-08-14Labeling · Supplement 12AP
2003-06-06Labeling · Supplement 11AP
2001-01-17Labeling · Supplement 10AP
1999-10-01Labeling · Supplement 9AP
1999-04-23Manufacturing (CMC) · Supplement 8AP
1998-02-05Manufacturing (CMC) · Supplement 7AP
1995-09-06Labeling · Supplement 6AP
1993-11-16Manufacturing (CMC) · Supplement 5AP
1993-05-14Labeling · Supplement 3AP
1992-07-10Labeling · Supplement 2AP
1991-07-10Manufacturing (CMC) · Supplement 1AP
1990-06-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →